Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
DCTN2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
POLR2J4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
SNORA68 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ATG16L1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
METTL26 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
USP5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
WWC1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF438 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CPM - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LAS1L - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GOLGA4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IQCA1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PSG6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DNAJC10 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DLX4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DOCK1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PARP10 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on